Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has raised CNY 20 million in a round of funding on August 21, 2023. The transaction included participation from new investors, Anhui Huaheng Biotechnology Co., Ltd. and Suzhou Kaifeng Zhengde Investment Management Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
121 CNY | -2.22% | +2.16% | -3.91% |
Apr. 22 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
Apr. 22 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.91% | 2.63B | |
+2.37% | 29.86B | |
+20.02% | 24.81B | |
+6.21% | 11.19B | |
+18.74% | 5.44B | |
+20.42% | 4.54B | |
-9.27% | 3.79B | |
+2.35% | 3.36B | |
+4.52% | 3.12B | |
+29.28% | 2.86B |
- Stock Market
- Equities
- 688639 Stock
- News Anhui Huaheng Biotechnology Co., Ltd.
- Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has received CNY 20 million in funding from Anhui Huaheng Biotechnology Co., Ltd., Suzhou Kaifeng Zhengde Investment Management Co., Ltd.